Pillstats
Rx only · Tablet, Film Coated · Oral

Ferric Citrate

Brands: Auryxia · Tetraferric Tricitrate Decahydrate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1594675
US makers3 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.98$3.96$5.94$7.92Dec 2025Mar 2026Apr 2026
$6.741
Latest avg · Apr 22, 2026
-0%
Since Dec 17, 2025
3
Active US suppliers
67%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.6K5.2K7.7K10K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.4K
Rx · 2026 Q1
847K
Units dispensed
-40%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Teva Pharmaceuticals USA, Inc.unknown1SUPPLYING
Mylan Pharmaceuticals Inc.unknown1SUPPLYING
Akebia Therapeutics, Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 15, 2021
    RECALLRecall (Class II): Auryxia (ferric citrate) tablets 210 mg* 200 Tablets Rx Only NDC 59922-631-01 Manufactured for and distributed by: Kery…

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC

  • Dec 9, 2020
    RECALLRecall (Class II): Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHA…

    CGMP Deviations — Recalling firm: Akebia Therapeutics dba Keryx Biopharmaceutials, Inc — The product was distributed by two major distributors who further distributed the product nationwide and one specialty …

  • Jul 10, 2020
    RECALLRecall (Class II): Auryxia (ferric citrate) tablets 210 mg, Rx Only, 200 tablets per bottle, Manufactured for and distributed by: Keryx Bi…

    cGMP deviations: Lots recalled were not manufactured in conformance with the FDA-approved manufacturing process for Auryxia. — Recalling firm: Keryx Biopharmaceuticals, Inc. — Nationwide in the U.S.

  • Dec 12, 2017
    RECALLRecall (Class III): Auryxia (ferric citrate) tablets, 210 mg , 200-count bottles, RX ONLY, Manufactured for and distributed by: Keryx Bioph…

    Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to make contact with Auryxia tablets in the bottle. — Recalling firm: Keryx Biopharmaceuticals, Inc. — Distributed nationwide in the USA